Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Thanks, and you're welcome, glad you found it help

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155111
(Total Views: 564)
Posted On: 03/31/2020 2:19:31 PM
Posted By: BlackDoggie
Re: Rubraquercus #24343
Thanks, and you're welcome, glad you found it helpful. As to the question of why the delays, my personal opinion is that it's one part sins of the past from long ago coming back to haunt them, one part insufferable FDA bureaucracy, and one part money being tight. Although at times I've wished that they would focus and get this one thing done, in the end I think it's been wise to chase the extracurriculars and it probably hasn't slowed them down much.

Sins of the past:

- In short, the vast majority of delays seem to be due to questions about appropriate or preferred dosages. The earliest P1 trials - from before the days of NP and CytoDyn even - should have probably done a better job of finding a maximum tolerable dosage, etc. They didn't, and one way or another, we wound up doing the combo P2/3 trial with 350mg originally. Eventually we were running mono trials as well, moved to 525mg then 700mg, were mixing trial protocols a bit... and all of the sudden you simply have a mess where the FDA has to figure out what it wants and the company has to respond to that. A more thought out, consistent clinical program would have been more efficient. Not all of that is NP's fault, some of it was likely a result of him learning on the go though. To the point that trding has made before, however, most "experienced" CEO's probably wouldn't have even tried any of this and wouldn't have the company or drug where it is now.

FDA is a huge bureaucracy

- I'm not going to expand on this one much, but the FDA is simply slow and bureaucracies are inefficient and innately poor structures for adapting quickly to new circumstances. Everything takes time, and the process is inscrutable looking from the outside in. If you're interested in why this is so innate to bureaucracy, skim or read "The Essence of Decision" by Allison and Zelikow. Fascinating read, in my opinion, but also does a great job of academically explaining the characteristics of bureaucracies that make them inefficient decision makers. The FDA is no exception.

Lack of money

- Simple. We're paying Amarex to put the BLA together. We're paying AGC for the stability data, etc. We've been asking to defer payments, put it on a credit card, etc. Ask any of the many lawyers here... the client with the money gets the work done first. We finally have the money to pay them, so I'm pretty confident that it'll get finished up at this point.


Aside from the money issue, I don't think that cancer, etc., has played a major part in the slow down. And at the moment, I'd say that money spent on cancer and coronavirus has been money well spent, even if you couldn't have necessarily foreseen it playing out this way.



(10)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us